A carregar...
Atezolizumab-Induced Bell’s Palsy in a Patient With Small Cell Lung Cancer
Immune checkpoint inhibitors are rapidly becoming popular therapeutic options for patients suffering from a number of malignancies. Atezolizumab is a programmed cell death ligand-1 inhibitor, and binding to this ligand decreases the ability of tumor cells to evade the immune system, resulting in sel...
Na minha lista:
| Publicado no: | J Investig Med High Impact Case Rep |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7557644/ https://ncbi.nlm.nih.gov/pubmed/33047629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709620965010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|